지질 패널 검사 시장 : 검사 유형별, 제품 유형별, 용도별, 처방 형태별, 최종사용자별, 지역별

Lipid Panel Test Market is estimated to be valued at USD 11.82 Bn in 2025 and is expected to reach USD 20.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.

The global lipid panel test market represents a critical segment of the clinical diagnostics industry, encompassing comprehensive blood tests that measure various cholesterol and triglyceride levels to assess cardiovascular disease risk. Lipid panel tests, also known as lipid profiles or lipograms, evaluate total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides in patients' blood samples.

These diagnostic assessments serve as fundamental screening tools for healthcare providers to identify individuals at risk of developing atherosclerosis, coronary artery disease, and other cardiovascular complications. The market encompasses various testing methodologies including enzymatic assays, homogeneous assays, and advanced automated analyzers deployed across hospitals, diagnostic laboratories, and point-of-care settings.

With the increasing prevalence of lifestyle-related diseases, aging populations, and growing awareness of preventive healthcare measures, the demand for lipid panel testing continues to expand globally. The integration of technological advancements such as high-throughput analyzers, portable testing devices, and digital health platforms has revolutionized the accessibility and efficiency of lipid testing procedures, making them more convenient for both healthcare providers and patients across diverse healthcare settings worldwide.

Market Dynamics

The global lipid panel test market is primarily driven by the escalating prevalence of cardiovascular diseases, diabetes, and obesity worldwide, creating substantial demand for regular lipid monitoring and screening procedures. The aging global population, particularly in developed countries, significantly contributes to market growth as elderly individuals require frequent cardiovascular risk assessments and lipid profile monitoring.

Technological advancements in diagnostic equipment, including the development of high-throughput automated analyzers, point-of-care testing devices, and portable lipid testing solutions, enhance testing accuracy, efficiency, and accessibility, thereby driving market expansion. Government initiatives promoting preventive healthcare measures, cardiovascular disease screening programs, and healthcare awareness campaigns further stimulate market demand.

However, the market faces certain restraints including high costs associated with advanced diagnostic equipment and testing procedures, which may limit accessibility in resource-constrained healthcare settings and developing regions. Stringent regulatory requirements for diagnostic device approvals, quality control standards, and laboratory certifications create barriers to market entry and increase compliance costs for manufacturers. Limited healthcare infrastructure, shortage of skilled laboratory professionals, and inadequate reimbursement policies in certain regions also hinder market growth.

Nevertheless, significant opportunities exist in emerging markets with expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness about cardiovascular health. The integration of artificial intelligence, machine learning algorithms, and telemedicine platforms presents opportunities for developing innovative lipid testing solutions and remote monitoring capabilities. The rising trend of home-based healthcare and self-monitoring devices creates potential for consumer-friendly lipid testing products, while partnerships between diagnostic companies and healthcare providers can facilitate market penetration and service expansion globally.

Key Features of the Study

• This report provides in-depth analysis of the global lipid panel test market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global lipid panel test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, SD Biosensor, Inc., PTS Diagnostics, Horiba Medical, Elitech Group, Menarini Group, VivaChek Biotech (Hangzhou) Co., Ltd., and Mico Bio Med.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global lipid panel test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lipid panel test market

Market Segmentation

• Test Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Standard Lipid Profile
  • Total Cholesterol
  • Triglycerides
  • Low-Density Lipoprotein (LDL) Cholesterol
  • High-Density Lipoprotein (HDL) Cholesterol
  • Advanced Lipid Testing
  • LDL Particle Number (LDL-P)
  • Apolipoprotein B (ApoB)
  • Lipoprotein(a) (Lp(a))
  • Others (HDL Subclasses, VLDL Cholesterol etc.)
• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Devices
  • Automated Analyzers
  • Point-of-Care Testing Devices
  • Spectrophotometers
  • Others
  • Reagents and Kits
  • Cholesterol Test Kits
  • HDL and LDL Kits
  • Triglyceride Test Kits
  • Test Strips
  • Other Product Types
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Familial Hypercholesterolemia
  • Hypo Lipoproteinemia
  • Tangier Disease
  • Atherosclerosis
  • Other Lipid Disorders
• Prescription Mode Insights (Revenue, USD Bn, 2020 - 2032)
  • Prescription-Based Testing
  • Over-the-Counter (OTC) Testing
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Specialty Clinics
  • Pathology Laboratories
  • Diagnostic Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Academic and Research Institutes
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Hoffmann-La Roche Ltd.
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories Inc.
  • Nova Biomedical Corporation
  • SD Biosensor, Inc.
  • PTS Diagnostics
  • Horiba Medical
  • Elitech Group
  • Menarini Group
  • VivaChek Biotech (Hangzhou) Co., Ltd.
  • Mico Bio Med

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Lipid Panel Test Market, By Test Type
  • Global Lipid Panel Test Market, By Product Type
  • Global Lipid Panel Test Market, By Application
  • Global Lipid Panel Test Market, By Prescription Mode
  • Global Lipid Panel Test Market, By End User
  • Global Lipid Panel Test Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Lipid Panel Test Market, By Test Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Standard Lipid Profile
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Total Cholesterol
    • Triglycerides
    • Low-Density Lipoprotein (LDL) Cholesterol
    • High-Density Lipoprotein (HDL) Cholesterol
• Advanced Lipid Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • LDL Particle Number (LDL-P)
    • Apolipoprotein B (ApoB)
    • Lipoprotein(a) (Lp(a))
    • Others (HDL Subclasses, VLDL Cholesterol etc.)

5. Global Lipid Panel Test Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Automated Analyzers
    • Point-of-Care Testing Devices
    • Spectrophotometers
    • Others
• Reagents and Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Cholesterol Test Kits
    • HDL and LDL Kits
    • Triglyceride Test Kits
    • Test Strips
    • Other Product Types

6. Global Lipid Panel Test Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hyperlipidemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hypertriglyceridemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Familial Hypercholesterolemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hypo Lipoproteinemia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tangier Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Atherosclerosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Lipid Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lipid Panel Test Market, By Prescription Mode, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Prescription-Based Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Over-the-Counter (OTC) Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lipid Panel Test Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pathology Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Lipid Panel Test Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Beckman Coulter Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Randox Laboratories Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthcare GmbH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Nova Biomedical Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• SD Biosensor, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• PTS Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Horiba Medical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Elitech Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Menarini Group
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• VivaChek Biotech (Hangzhou) Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Mico Bio Med
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us